Back to SVA
ORBIMED ADVISORS LLC SVA Position History
Sinovac Biotech, Ltd. • Healthcare
Quarters held
4
Latest value
$195.5M
Q3 2026
Peak value
$195.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $184.5M |
| Q1 2026 | $184.5M |
| Q2 2026 | $184.5M |
| Q3 2026 | $195.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $195.5M | 2.72M | — | — |
| Q2 2026 | $184.5M | 2.72M | — | — |
| Q1 2026 | $184.5M | 2.72M | — | — |
| Q4 2025 | $184.5M | 2.72M | — | — |